789 results on '"Alvarez, Jean-Claude"'
Search Results
2. Correction to: Evaluation of the cardiovascular risk induced by cannabis use from a series of 43 autopsy cases
3. Evaluation of the cardiovascular risk induced by cannabis use from a series of 43 autopsy cases
4. Ketamine metabolism via hepatic CYP450 isoforms contributes to its sustained antidepressant actions
5. Characterizing the risk related to the exposure to methylmercury over a lifetime: A global approach using population internal exposure
6. Body fluid contamination in the context of an adverse analytical finding in doping: About a case involving ostarine
7. Valproic acid as adjuvant treatment for convulsive status epilepticus: a randomised clinical trial
8. Hair and dietary supplements testing to identify contamination with roxadustat in an adverse analytical finding
9. « Chemsex » et cathinones
10. Assessment of 19 years of a prospective national survey on drug-facilitated crimes in France
11. Le cannabidiol (CBD) : aspects analytiques et toxicologiques
12. Étude nationale du phénomène du chemsex en France : une collaboration interlaboratoire sous l’égide de la Société française de toxicologie analytique (SFTA)
13. A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial
14. First detection/quantification of roxadustat in hair with a new liquid chromatography with tandem mass spectrometry method: Application to a treated patient
15. Indoxyl sulfate impairs erythropoiesis at BFU-E stage in chronic kidney disease
16. Décès préhospitaliers liés au fentanyl et ses analogues en Île-de-France : données du dispositif de surveillance des Décès Toxiques en Île-de-France (DCTOX-IdF)
17. Intranasal (R, S)-ketamine delivery induces sustained antidepressant effects associated with changes in cortical balance of excitatory/inhibitory synaptic activity
18. Toxicological analysis of a "poison vial" found in the remains of an SS soldier (Maltot, Normandy, France)
19. Target Analysis of Designer Benzodiazepines in Blood and Urine
20. Plasma concentrations of antiretroviral drugs in a successful 4-days-a-week maintenance treatment strategy in HIV-1 patients (ANRS 170-Quatuor trial)
21. Ketamine metabolism via hepatic CYP450 isoforms contributes to its sustained antidepressant actions
22. Le cannabidiol (CBD) : que faut-il retenir ?
23. The association between TMAO, CMPF, and clinical outcomes in advanced chronic kidney disease: results from the European QUALity (EQUAL) Study
24. High frequency repetitive Transcranial Magnetic Stimulation promotes long lasting phrenic motoneuron excitability via GABAergic networks
25. Analysis of pharmaceutical products and dietary supplements seized from the black market among bodybuilders
26. Metoclopramide Intoxication Through Breast Milk: Relevance of Blood and Hair Analyses
27. Cannabis : quels examens biologiques en milieu hospitalier ?
28. Quantification of free and protein bound uremic toxins in human serum by LC-MS/MS: Comparison of rapid equilibrium dialysis and ultrafiltration
29. Validation of Liquid Chromatography Coupled with Tandem Mass Spectrometry for the Determination of 12 Tyrosine Kinase Inhibitors (TKIs) and Their Application to Therapeutic Drug Monitoring in Adult and Pediatric Populations
30. « Chemsex » et cathinones
31. Hair and dietary supplements testing to identify contamination with roxadustat in an adverse analytical finding
32. Can inhaled cannabis users accurately evaluate impaired driving ability? A randomized controlled trial
33. Association between Dental Scores and Saliva Uremic Toxins
34. Hair testing for 3-fluorofentanyl, furanylfentanyl, methoxyacetylfentanyl, carfentanil, acetylfentanyl and fentanyl by LC–MS/MS after unintentional overdose
35. Attempt of scopolamine-facilitated robbery: an original case of poisoning by inhalation confirmed by LC–MS/MS and review of the literature
36. Identification et dosage de la mitragynine dans les cheveux : à propos d’un cas d’un consommateur régulier de substances psychotropes achetées sur le dark web
37. A high-resolution ICP-MS method for the determination of 38 inorganic elements in human whole blood, urine, hair and tissues after microwave digestion
38. 7 Cocaïne et crack
39. Synthetic cannabinoid isomers characterization by MALDI-MS3 imaging: Application to single scalp hair
40. Study of the association between serum levels of kynurenine and cardiovascular outcomes and overall mortality in chronic kidney disease.
41. Validation of Liquid Chromatography Coupled with Tandem Mass Spectrometry for the Determination of 12 Tyrosine Kinase Inhibitors (TKIs) and Their Application to Therapeutic Drug Monitoring in Adult and Pediatric Populations.
42. Evaluation of drug abuse by hair analysis and self-reported use among MSM under PrEP: Results from a French sub-study of the ANRS-IPERGAY trial.
43. Evaluation of Drug Abuse by Hair Analysis and Self-Reported Use Among MSM Under PrEP: Results From a French Substudy of the ANRS-IPERGAY Trial
44. Does the Administration of Sevelamer or Nicotinamide Modify Uremic Toxins or Endotoxemia in Chronic Hemodialysis Patients?
45. Poisoning associated with inappropriate use of a eutectic mixture of lidocaine and prilocaine before laser-assisted hair removal: about 3 cases
46. Management of pharmaceutical and recreational drug poisoning
47. Reply to the letter to the Editor “Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts”
48. Characterization of extensive 2-fluorodeschloroketamine metabolism in pooled human liver microsomes, urine and hair from an addicted patient using high-resolution accurate mass spectrometry
49. #3953 TOXIC MICROBIOME AND CHRONIC KIDNEY DISEASE: INSIGHTS FROM THE CKD-REIN COHORT STUDY
50. #3386 PROTON-PUMP INHIBITORS AND SERUM CONCENTRATIONS OF UREMIC TOXINS IN PATIENTS WITH CHRONIC KIDNEY DISEASE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.